We are international
Donate
• health professionals TEXT SIZE   
webcasts    back

Long-Term Follow-Up of a Phase II Trial of Vel/Dex in Frontline Therapy for Myeloma
By Sundar Jagannath, MD
12.17.06

Be the first to comment

 related articles